-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WBMojau2uw0UwQSJm8TnS/8gkMJcq/82nSrpKTtAcBH0duzVI0eMkA+MO6dm0RDD Y2Iy/B9rHeyJsD0hUIA4Bg== 0000919574-00-000468.txt : 20000329 0000919574-00-000468.hdr.sgml : 20000329 ACCESSION NUMBER: 0000919574-00-000468 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19970328 FILED AS OF DATE: 20000328 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NOVAVAX INC CENTRAL INDEX KEY: 0001000694 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222816046 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: SEC FILE NUMBER: 000-26770 FILM NUMBER: 581577 BUSINESS ADDRESS: STREET 1: 8320 GUILFORD RD STREET 2: SUITE C CITY: COLUMBIA STATE: MD ZIP: 21046 BUSINESS PHONE: 3078543900 MAIL ADDRESS: STREET 1: 8320 GUILFORD ROAD SUITE C CITY: COLUMBIA STATE: MD ZIP: 21046 COMPANY DATA: COMPANY CONFORMED NAME: ANACONDA OPPORTUNITY FUND L P CENTRAL INDEX KEY: 0001021863 STANDARD INDUSTRIAL CLASSIFICATION: [] OWNER IRS NUMBER: 521945748 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 3 BUSINESS ADDRESS: STREET 1: 730 FIFTH AVENUE 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2125741286 MAIL ADDRESS: STREET 1: 730 FIFTH AVENUE STREET 2: 15TH FL CITY: NEW YORK STATE: NY ZIP: 10019 3 1 8p UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 1. Name and Address of Reporting Person Anaconda Opportunity Fund, L.P. c/o Anaconda Capital Management, LLC 730 Fifth Avenue, 15th Floor New York, New York 10019 2. Date of Event Requiring Statement (Month/Day/Year) March 13, 1997 3. IRS Number of Reporting Person (Voluntary) 4. Issuer Name and Ticker or Trading Symbol Novavax, Inc. (NOX) 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) ( ) Director (X) 10% Owner ( ) Officer (give title below) ( ) Other (specify below) 6. If Amendment, Date of Original (Month/Day/Year) 7. Individual or Joint/Group Filing (Check Applicable Line) (X) Form filed by One Reporting Person ( ) Form filed by More than One Reporting Person Table I -- Non-Derivative Securities Beneficially Owned 1. Title of Security 2. Amount of 3. Ownership 4. Nature of Indirect Securities Form: Beneficial Ownership Beneficially Direct(D) or Owned Indirect(I) Common Stock 1,222,900 (D) Table II -- Derivative Securities Beneficially Owned 1.Title of 2.Date Exer- 3.Title and Amount 4. Conver- 5. Ownership 6. Nature of Derivative cisable and of Securities sion or Form of Indirect Security Expiration Underlying Exercise Derivative Beneficial Date Derivative Security Price of Security: Ownership (Month/Day/ --------------- Deri- Direct(D) or Year) Title Amount or vative Indirect (I) --------------- Number of Security Date Expira- Shares Exer- tion cisable Date Warrants Immed. 3/12/00 Common 600,000 $6.00 (D) Stock Warrants Immed. 3/12/00 Common 600,000 $8.00 (D) Stock
Explanation of Responses: SIGNATURE OF REPORTING PERSON Anaconda Opportunity Fund, L.P. By: /s/ Mitchell J. Kelly ___________________________ NAME: Mitchell J. Kelly TITLE: Managing General Partner DATE: March 28, 20000 2 01474003.AB8
-----END PRIVACY-ENHANCED MESSAGE-----